Skip to main content

Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to September 2026.

37,066
Total recall recordsAll FDA and USDA recalls in Public Health Trace
9,786
Class I recallsReasonable probability of serious health consequences
24,313
Class II recallsTemporary or medically reversible health consequences
2,876
Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls
Most common hazardLack of Assurance of Sterility 2,072 recalls
Most affected stateHawaii 200 recalls mention this state

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters
Recall details
Location
Date range
Sort results
Clear filters
Metric
View
Recalls announced by month (Year to date)

A chart of recalls grouped by month.

Download CSV

Source: FDA and USDA public dataLast updated

Summary (Year to date)

  • 1,527 recalls have been announced year to date.
  • Aug 2026 was 24% lower than the previous complete period (Jul 2026: 240).
  • The highest complete period was Jun 2026 (297).
  • Sep 2026 is incomplete and not included in the figures above.
  • Complete data
  • Incomplete
Recalls by class

A bar chart of the total number of recalls in this dataset by recall class.

Recalls by class
ClassRecalls
Class II24,313
Class I9,786
Class III2,876
Not Yet Classified2
Download CSV
Recalls by class
ClassRecalls
Class II24,313
Class I9,786
Class III2,876
Not Yet Classified2

Showing 4,781–4,800 of 17,299 recalls

FDA Recall Terminated Historical recordClass II

Lidocaine 2.5% and Prilocaine 2.5% Cream, USP, packaged in a) 5 g tubes (NDC 0591-2070-72), b) 30 g tubes (NDC 0591-2070-30), Rx Only, Manufactured by: Teligent Pharma, Inc., Buena, NJ 08310, USA, Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054, USA

by Teva Pharmaceuticals USA Inc

Reason
cGMP Deviations
Published
May 4, 2022
Distribution
Nationwide

View recall →

FDA Recall Completed Historical recordClass II

Zonisamide Capsules, USP, 100 mg, packaged in: a) 100-count bottle (NDC 68462-130-01); b) 500-count bottle (NDC 68462-130-05), Rx only, Manufactured by: Glenmark Pharmaceuticals, Inc., USA Monroe, NC 28110, Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430

by Glenmark Pharmaceuticals Inc., USA

Reason
cGMP deviations
Published
May 4, 2022
Distribution
Nationwide

View recall →

FDA Recall Completed Historical recordClass II

Zonisamide Capsules, USP, 50 mg, packaged in 100-count bottles, Rx only, Manufactured by: Glenmark Pharmaceuticals, Inc., USA Monroe, NC 28110, Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430, NDC 68462-129-01

by Glenmark Pharmaceuticals Inc., USA

Reason
cGMP deviations
Published
May 4, 2022
Distribution
Nationwide

View recall →

FDA Recall Completed Historical recordClass II

Zonisamide Capsules USP, 25 mg, packaged in 100-count bottles, Rx Only, Manufactured by: Glenmark Pharmaceuticals, Inc., USA Monroe, NC 28110, Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430, NDC 68462-128-01

by Glenmark Pharmaceuticals Inc., USA

Reason
cGMP deviations
Published
May 4, 2022
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Losartan Potassium Tab. USP 50mg, Pkg Size: 30, Mfg: Lupin Pharmaceuticals, Inc., Preferred Pharmaceuticals, Inc.

by Preferred Pharmaceuticals, Inc.

Reason
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits.
Published
May 4, 2022
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Suave 24-Hour Protection Aerosol Antiperspirant Fresh scent, Aluminum Chlorohydrate (19.1%), packaged in 6 oz. cans, Unilever, Dist. By Unilever, Trumbull, CT 06611 UPC 0 79400 78550 3

by Unilever United States Inc.

Reason
CGMP Deviation; manufactured at the same facility where other lots were found to be contaminated with benzene
Published
May 4, 2022
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass I

Suave 24-Hour Protection Aerosol Antiperspirant Powder scent, Aluminum Chlorohydrate (19.1%), packaged in a) 4 oz. cans (UPC 0 79400 75150 8), and b) 6 oz. cans (UPC 0 79400 78490 2), Dist. By Unilever, Trumbull, CT 06611

by Unilever United States Inc.

Reason
Chemical contamination: presence of benzene
Published
May 4, 2022
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

artnaturals Hand Sanitizer

by VIRGIN SCENT INC

Reason
CGMP Deviations: Other lots recalled because they were manufactured using common ingredients as the contaminated lot
Published
April 27, 2022
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

artnaturals hand sanitizer, SCENT FREE HAND SANITIZER (ethyl alcohol 62.5%), 8 fl oz (236 ml) bottles, Dist. By artnaturals, Gardena, CA 90248, UPC: 8 16820 02820 5

by VIRGIN SCENT INC

Reason
Chemical Contamination: presence of benzene, acetaldehyde, and acetal.
Published
April 27, 2022
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

LL-37 2 mg/mL (5 mL) Injection, 5 mL vials, Rx only, Farmakeio 1736 N Greenville Ave Richardson, TX 75081 USA

by North American Custom Laboratories, LLC dba FarmaKeio Superior Custom Compounding

Reason
Lack of Assurance of Sterility: deviations from Current Good Manufacturing Practices (CGMP) that call into question the sterility of products intended to be sterile.
Published
April 27, 2022
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

BPC-157 2 mg/mL (5 mL) Injection, 5 mL vials, Rx Only, Farmakeio 1736 N Greenville Ave Richardson, TX 75081

by North American Custom Laboratories, LLC dba FarmaKeio Superior Custom Compounding

Reason
Lack of Assurance of Sterility: deviations from Current Good Manufacturing Practices (CGMP) that call into question the sterility of products intended to be sterile.
Published
April 27, 2022
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

Pink Pussycat SENSUAL ENHANCEMENT capsule, 3000mg, 1-count blister card, Manufactured for: Pink Pussycat Products - Chatsworth, CA 91311, UPC 8 91875 00462 6.

by Pink Toyz

Reason
Marketed Without An Approved NDA/ANDA: FDA analysis found the product to contain undeclared sildenafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.
Published
April 27, 2022
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

artnaturals hand sanitizer, SCENT FREE HAND SANITIZER (ethyl alcohol 62.5%), 8 fl oz (236 ml) bottles, Dist. By artnaturals, Gardena, CA 90248, UPC: 8 16820 02820 5

by VIRGIN SCENT INC

Reason
CGMP Deviations: Other lots recalled because they were manufactured using common ingredients as the contaminated lot
Published
April 27, 2022
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Sermorelin Acetate 1 mg/mL (6 mL) Injection, 6 mL vials, Rx only, Farmakeio 1736 N Greenville Ave Richardson, TX 75081

by North American Custom Laboratories, LLC dba FarmaKeio Superior Custom Compounding

Reason
Lack of Assurance of Sterility: deviations from Current Good Manufacturing Practices (CGMP) that call into question the sterility of products intended to be sterile.
Published
April 27, 2022
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

PT-141 (Bremelanotide Acetate) 10 mg/mL (2 mL) Injection, 2mL vials, Rx Only, Farmakeio 1736 N Greenville Ave Richardson, TX 75081

by North American Custom Laboratories, LLC dba FarmaKeio Superior Custom Compounding

Reason
Lack of Assurance of Sterility: deviations from Current Good Manufacturing Practices (CGMP) that call into question the sterility of products intended to be sterile.
Published
April 27, 2022
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Melanotan II 1 mg/mL (10 mL) Injection, 10mL vials, Rx only, Farmakeio 1736 N Greenville Ave Richardson, TX 75081 USA

by North American Custom Laboratories, LLC dba FarmaKeio Superior Custom Compounding

Reason
Lack of Assurance of Sterility: deviations from Current Good Manufacturing Practices (CGMP) that call into question the sterility of products intended to be sterile.
Published
April 27, 2022
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Ipamorelin Acetate/Sermorelin Acetate (1 mg/1 mg)/mL (10 mL) Injection, 10 mL vials, Rx Only, Farmakeio 1736 N Greenville Ave Richardson, TX 75081

by North American Custom Laboratories, LLC dba FarmaKeio Superior Custom Compounding

Reason
Lack of Assurance of Sterility: deviations from Current Good Manufacturing Practices (CGMP) that call into question the sterility of products intended to be sterile.
Published
April 27, 2022
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

ARA-290 (Cibinetide Acetate) 6 mg/mL (4 mL) Injection, 4 mL vials, Rx only, Farmakeio 1736 N Greenville Ave Richardson, TX 75081 USA

by North American Custom Laboratories, LLC dba FarmaKeio Superior Custom Compounding

Reason
Lack of Assurance of Sterility: deviations from Current Good Manufacturing Practices (CGMP) that call into question the sterility of products intended to be sterile.
Published
April 27, 2022
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Rifampin for Injection, USP, 600 mg/vial, One Vial per carton, Rx only, Manufactured for: Mylan Institutional LLC, Morgantown, WV 26505 U.S.A., NDC 67457-445-60

by MYLAN PHARMACEUTICALS INC

Reason
Failed Impurities/Degradation Specifications: High out of specification results obtained for related compound during stability testing.
Published
April 27, 2022
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Diclofenac Sodium Topical Solution 1.5% w/w, Generic for Pennsaid, 150 ml bottle, Rx Only, Mfg: Sola Pharmaceutical, Preferred Pharmaceuticals, Inc., The Physicians Solutions, NDC 68788-7918-01

by Preferred Pharmaceuticals, Inc.

Reason
CGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc. is discontinuing its stability study program.
Published
April 27, 2022
Distribution
Nationwide

View recall →

Data last updated:

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.